AI

Qustella Raises ¥110M for AI Cell Quality Tool Cytometa

Quastella Inc., a startup in Nagoya, has raised 110 million yen. They got this funding through a third-party allotment and a loan from The Juroku Bank. The funding round included investments from Aichi Startup Fund No. 1 and Data Driven Innovation Investment, managed by Aichi Capital and epiST Ventures. The company creates Cytometa. It's an AI-powered quality control system for cell manufacturing. Traditionally, skilled technicians inspected cell quality. This method often leads to inconsistencies. It’s hard to scale up, and subtle defects can be missed. Cytometa tackles these challenges with a standard, image-based evaluation system. This system measures cell quality during production in a clear, quantitative way. To help with adoption, Quastella  provides a Proof-of-Concept (PoC) support service. This service assists manufacturers in customizing the AI system for their unique…